Kestra Medical Technologies, Ltd. Common Stock KMTS Income Statement
| Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | ||
|---|---|---|---|---|---|---|
| $24.55M+62.7% | $22.57M+53.4% | $19.37M+51.5% | $17.23M+148% | $15.09M+117% | ||
| $11.65M+36.3% | $11.14M+25.5% | $10.52M+22.6% | $9.6M+39.9% | $8.54M+24.5% | ||
| $12.91M+97.1% | $11.42M+96.0% | $8.85M+111% | $7.63M+8,334% | $6.55M+7,134% | ||
| 52.6%+9.2pp | 50.6%+11.0pp | 45.7%+12.8pp | 44.3%+43.0pp | 43.4%+42.1pp | ||
| $4.97M+48.3% | $4.88M+39.0% | $4M+17.5% | $5.39M+39.1% | $3.35M-13.4% | ||
| $42.7M+79.4% | $38.3M+78.5% | $33.73M+75.4% | $50.46M+189% | $23.8M+36.1% | ||
| $47.67M+75.6% | $43.18M+73.0% | $37.73M+66.7% | $55.85M+161% | $27.15M+27.1% | ||
| $47.67M+75.6% | $43.18M+73.0% | $37.73M+66.7% | $55.85M+161% | $27.15M+27.1% | ||
| -$34.77M-68.8% | -$31.76M-66.0% | -$28.88M-56.7% | -$48.21M-127% | -$20.6M+3.1% | ||
| -141.6%-5.1pp | -140.7%-10.7pp | -149.1%-4.9pp | -279.8%+26.1pp | -136.5%+169pp | ||
| $1.89M+5.9% | $1.9M-18.0% | $1.91M+2.0% | $1.76M+13.0% | $1.78M+14.5% | ||
| $2.16M+244% | $1.8M+105% | $2.17M+5,757% | $1.66M— | $628K— | ||
| $359K+2,293% | -$891K-2,128% | $2.83M+5,996% | -$2.69M-284% | $15K+102% | ||
| -$34.13M-57.0% | -$32.75M-58.9% | -$25.79M-27.0% | -$51.01M-117% | -$21.74M+7.6% | ||
| $35K+94.4% | $34K+325% | $33K+371% | $102K+1,600% | $18K+200% | ||
| -$34.17M-58.8% | -$32.79M-61.0% | -$25.83M-29.9% | -$52.05M-121% | -$21.51M+8.6% | ||
| -139.2%+3.4pp | -145.3%-6.8pp | -133.3%+22.2pp | -302.1%+36.3pp | -142.5%+196pp | ||
| —— | —— | —— | $3.29M+95.9% | $3.32M+97.8% | ||
| -$0.61+51.2% | -$0.64+46.2% | -$0.50+55.4% | -$1.57-23.9% | -$1.25+1.4% | ||
| -$0.61+51.2% | -$0.64+46.2% | -$0.50+55.4% | -$1.57-23.9% | -$1.25+1.4% | ||
| 55.8M+181% | 51.4M+158% | 51.3M+158% | 24.6M+23.6% | 19.9M— | ||
| 55.8M+181% | 51.4M+158% | 51.3M+158% | 24.6M+23.6% | 19.9M— | ||
| $359K+2,293% | -$891K-2,128% | $2.83M+5,996% | -$2.69M-284% | $15K+102% | ||
| $24.55M+62.7% | $22.57M+53.4% | $19.37M+51.5% | $17.23M+148% | $15.09M+117% | ||
| -$34.77M-68.8% | -$31.76M-66.0% | -$28.88M-56.7% | -$48.21M-127% | -$20.6M+3.1% | ||
| -$32.78M-75.2% | -$29.38M-70.2% | -$26.85M-67.2% | -$46.38M-152% | -$18.71M-1.8% | ||
| -$32.78M-75.2% | -$29.38M-70.2% | -$26.85M-67.2% | -$46.38M-152% | -$18.71M-1.8% | ||
| -133.5%-9.5pp | -130.2%-12.8pp | -138.6%-13.0pp | -269.1%-4.8pp | -124%+140pp | ||
| -$34.77M-68.8% | -$31.76M-66.0% | -$28.88M-56.7% | -$48.21M-127% | -$20.6M+3.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Kestra Medical Technologies, Ltd. Common Stock's revenue?
- Kestra Medical Technologies, Ltd. Common Stock (KMTS) generated $83.7M in revenue over the trailing twelve months, up 69.0% year over year.
- Is Kestra Medical Technologies, Ltd. Common Stock profitable?
- Kestra Medical Technologies, Ltd. Common Stock is not currently profitable: it reported a net loss of $144.8M over the trailing twelve months, a -173.0% net margin.
- What are Kestra Medical Technologies, Ltd. Common Stock's profit margins?
- Gross margin is 48.8% and operating margin is -171.5%, with a -173.0% net margin.
- What is Kestra Medical Technologies, Ltd. Common Stock's earnings per share?
- Kestra Medical Technologies, Ltd. Common Stock's diluted EPS over the trailing twelve months is $-3.32.
- Where does Kestra Medical Technologies, Ltd. Common Stock's income statement data come from?
- Every line is extracted from Kestra Medical Technologies, Ltd. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
